Literature DB >> 30978362

Allergy to Mus m 1: Allergy to Mus m 1: A review of structural, and immunological features.

Marlon Múnera1, Andres Sanchez2, Jorge Sánchez3, Maria Nordmann4, Mariana Perez4, Dilia Aparicio2.   

Abstract

The prevalence of allergies to pets has been increasing over the past decades. Some of the most important animal-derived allergens are members of the lipocalin protein family, which are found in dander, saliva, and urine. These allergens disperse effectively and are widely present in indoor environments. Exposure to high levels of mouse urinary protein (Mus m 1, hereinafter called 'mouse allergen') has been previously linked to sensitization to mouse, and indicators of asthma severity or control in some studies. To date, this is the only known mouse allergen registered in the IUIS database. This allergen is responsible for 27% of the total T cell response, confirming the dominant role it plays in mouse allergy. Mice have a worldwide distribution affecting both rural and urban areas; hence humans are frequently exposed to mouse-derived proteins. Additionally, exposure to mouse allergens has increased since they are more frequently being made pets, and in addition, exposure of laboratory animal care personnel to mice has been associated with a high risk of developing occupational allergies. Mus m 1 has been recognized as the main mouse allergen, and several studies suggest its clinical relevance. What makes Mus m 1 such an important allergen? In this review, we explored its structural, immunological, and clinical features.
Copyright © 2019 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30978362     DOI: 10.1016/j.imlet.2019.03.012

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  1 in total

1.  In silico analysis of a major allergen from Rattus norvegicus, Rat n 1, and cross-reactivity with domestic pets.

Authors:  Marlon Munera; Neyder Contreras; Andres Sánchez; Jorge Sánchez; Yuliana Emiliani
Journal:  F1000Res       Date:  2019-10-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.